Chapter 4 Test part

This is a test

4.1 Test

Abou-Jaoudé, Wassim, Pauline Traynard, Pedro T Monteiro, Julio Saez-Rodriguez, Tomáš Helikar, Denis Thieffry, and Claudine Chaouiya. 2016. “Logical Modeling and Dynamical Analysis of Cellular Networks.” Frontiers in Genetics 7. Frontiers: 94.

Alberts, Bruce, Alexander Johnson, Julian Lewis, Martin Raff, Keith Roberts, and Peter Walter. 2007. “Molecular Biology of the Cell. Garland Science.” New York 1392.

Altrock, Philipp M, Lin L Liu, and Franziska Michor. 2015. “The Mathematics of Cancer: Integrating Quantitative Models.” Nature Reviews Cancer 15 (12). Nature Publishing Group: 730–45.

Anderson, Alexander RA, and Vito Quaranta. 2008. “Integrative Mathematical Oncology.” Nature Reviews Cancer 8 (3). Nature Publishing Group: 227–34.

Araujo, Robyn P, and DL Sean McElwain. 2004. “A History of the Study of Solid Tumour Growth: The Contribution of Mathematical Modelling.” Bulletin of Mathematical Biology 66 (5). Elsevier: 1039–91.

Armitage, Peter, and Richard Doll. 1954. “The Age Distribution of Cancer and a Multi-Stage Theory of Carcinogenesis.” British Journal of Cancer 8 (1). Nature Publishing Group: 1.

Bailer-Jones, Daniela M. 2002. “Scientists’ Thoughts on Scientific Models.” Perspectives on Science 10 (3). MIT Press: 275–301.

Baker, Ruth E, Jose-Maria Pena, Jayaratnam Jayamohan, and Antoine Jérusalem. 2018. “Mechanistic Models Versus Machine Learning, a Fight Worth Fighting for the Biological Community?” Biology Letters 14 (5). The Royal Society: 20170660.

Barabasi, Albert-Laszlo, and Zoltan N Oltvai. 2004. “Network Biology: Understanding the Cell’s Functional Organization.” Nature Reviews Genetics 5 (2). Nature Publishing Group: 101–13.

Barbolosi, Dominique, Joseph Ciccolini, Bruno Lacarelle, Fabrice Barlési, and Nicolas André. 2016. “Computational Oncology—mathematical Modelling of Drug Regimens for Precision Medicine.” Nature Reviews Clinical Oncology 13 (4). Nature Publishing Group: 242.

Barillot, Emmanuel, Laurence Calzone, Philippe Hupe, Jean-Philippe Vert, and Andrei Zinovyev. 2012. Computational Systems Biology of Cancer. CRC Press.

Behan, Fiona M, Francesco Iorio, Gabriele Picco, Emanuel Gonçalves, Charlotte M Beaver, Giorgia Migliardi, Rita Santos, et al. 2019. “Prioritization of Cancer Therapeutic Targets Using Crispr–Cas9 Screens.” Nature 568 (7753). Nature Publishing Group: 511.

Bellomo, Nicola, NK Li, and Ph K Maini. 2008. “On the Foundations of Cancer Modelling: Selected Topics, Speculations, and Perspectives.” Mathematical Models and Methods in Applied Sciences 18 (04). World Scientific: 593–646.

Benzekry, Sébastien, Clare Lamont, Afshin Beheshti, Amanda Tracz, John ML Ebos, Lynn Hlatky, and Philip Hahnfeldt. 2014. “Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth.” PLoS Comput Biol 10 (8). Public Library of Science: e1003800.

Béal, Jonas, Elizabeth Rémy, and Laurence Calzone. 2020. “Modélisation Logique et Données Omiques : De La Construction Des Modèles à La Médecine Personnalisée.” In Approche Symbolique de La Modélisation et de L’analyse Des Systèmes Biologiques, edited by Elisabeth Rémy and Cédric Lhoussaine. ISTE.

Bhalla, Upinder S, and Ravi Iyengar. 1999. “Emergent Properties of Networks of Biological Signaling Pathways.” Science 283 (5400). American Association for the Advancement of Science: 381–87.

Bianucci, Raffaella, Antonio Perciaccante, Philippe Charlier, Otto Appenzeller, and Donatella Lippi. 2018. “Earliest Evidence of Malignant Breast Cancer in Renaissance Paintings.” The Lancet Oncology 19 (2). Elsevier: 166–67.

Bilal, Erhan, Janusz Dutkowski, Justin Guinney, In Sock Jang, Benjamin A Logsdon, Gaurav Pandey, Benjamin A Sauerwine, et al. 2013. “Improving Breast Cancer Survival Analysis Through Competition-Based Multidimensional Modeling.” PLoS Computational Biology 9 (5). Public Library of Science.

Bouhaddou, Mehdi, Anne Marie Barrette, Alan D Stern, Rick J Koch, Matthew S DiStefano, Eric A Riesel, Luis C Santos, Annie L Tan, Alex E Mertz, and Marc R Birtwistle. 2018. “A Mechanistic Pan-Cancer Pathway Model Informed by Multi-Omics Data Interprets Stochastic Cell Fate Responses to Drugs and Mitogens.” PLoS Computational Biology 14 (3). Public Library of Science: e1005985.

Bozic, Ivana, Tibor Antal, Hisashi Ohtsuki, Hannah Carter, Dewey Kim, Sining Chen, Rachel Karchin, Kenneth W Kinzler, Bert Vogelstein, and Martin A Nowak. 2010. “Accumulation of Driver and Passenger Mutations During Tumor Progression.” Proceedings of the National Academy of Sciences 107 (43). National Acad Sciences: 18545–50.

Braithwaite, Peter Allen, and Dace Shugg. 1983. “Rembrandt’s Bathsheba: The Dark Shadow of the Left Breast.” Annals of the Royal College of Surgeons of England 65 (5). Royal College of Surgeons of England: 337.

Bray, Freddie, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, and Ahmedin Jemal. 2018. “Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.” CA: A Cancer Journal for Clinicians 68 (6). Wiley Online Library: 394–424.

Breiman, Leo. 2001a. “Random Forests.” Machine Learning 45 (1). Springer: 5–32.

———. 2001b. “Statistical Modeling: The Two Cultures (with Comments and a Rejoinder by the Author).” Statistical Science 16 (3). Institute of Mathematical Statistics: 199–231.

Byrne, Helen M. 2010. “Dissecting Cancer Through Mathematics: From the Cell to the Animal Model.” Nature Reviews Cancer 10 (3). Nature Publishing Group: 221–30.

Calzone, Laurence, Emmanuel Barillot, and Andrei Zinovyev. 2018. “Logical Versus Kinetic Modeling of Biological Networks: Applications in Cancer Research.” Current Opinion in Chemical Engineering 21. Elsevier: 22–31.

Calzone, Laurence, Laurent Tournier, Simon Fourquet, Denis Thieffry, Boris Zhivotovsky, Emmanuel Barillot, and Andrei Zinovyev. 2010. “Mathematical Modelling of Cell-Fate Decision in Response to Death Receptor Engagement.” PLoS Computational Biology 6 (3). Public Library of Science.

Cohrs, Randall J, Tyler Martin, Parviz Ghahramani, Luc Bidaut, Paul J Higgins, and Aamir Shahzad. 2015. “Translational Medicine Definition by the European Society for Translational Medicine.” Elsevier.

Collins. 2020. The Collins English Dictionary. HarperCollins. https://www.collinsdictionary.com/dictionary/english/model.

Cortes, Corinna, and Vladimir Vapnik. 1995. “Support-Vector Networks.” Machine Learning 20 (3). Springer: 273–97.

Crick, Francis. 1970. “Central Dogma of Molecular Biology.” Nature 227 (5258). Nature Publishing Group: 561–63.

Davies, Helen, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, et al. 2002. “Mutations of the Braf Gene in Human Cancer.” Nature 417 (6892). Nature Publishing Group: 949–54.

De Jong, Hidde. 2002. “Modeling and Simulation of Genetic Regulatory Systems: A Literature Review.” Journal of Computational Biology 9 (1). Mary Ann Liebert, Inc.: 67–103.

Deisboeck, Thomas S, Le Zhang, Jeongah Yoon, and Jose Costa. 2009. “In Silico Cancer Modeling: Is It Ready for Prime Time?” Nature Clinical Practice Oncology 6 (1). Nature Publishing Group: 34–42.

Del Sol, Antonio, Rudi Balling, Lee Hood, and David Galas. 2010. “Diseases as Network Perturbations.” Current Opinion in Biotechnology 21 (4). Elsevier: 566–71.

Ding, Li, Matthew H Bailey, Eduard Porta-Pardo, Vesteinn Thorsson, Antonio Colaprico, Denis Bertrand, David L Gibbs, et al. 2018. “Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.” Cell 173 (2). Elsevier: 305–20.

Domany, Eytan. 2014. “Using High-Throughput Transcriptomic Data for Prognosis: A Critical Overview and Perspectives.” Cancer Research 74 (17). AACR: 4612–21.

Drier, Yotam, Michal Sheffer, and Eytan Domany. 2013. “Pathway-Based Personalized Analysis of Cancer.” Proceedings of the National Academy of Sciences 110 (16). National Acad Sciences: 6388–93.

Dulbecco, Renato. 1986. “A Turning Point in Cancer Research: Sequencing the Human Genome.” Science 231. American Association for the Advancement of Science: 1055–7.

Ferranti, Dana, David Krane, and David Craft. 2017. “The Value of Prior Knowledge in Machine Learning of Complex Network Systems.” Bioinformatics 33 (22). Oxford University Press: 3610–8.

Fey, Dirk, Melinda Halasz, Daniel Dreidax, Sean P Kennedy, Jordan F Hastings, Nora Rauch, Amaya Garcia Munoz, et al. 2015. “Signaling Pathway Models as Biomarkers: Patient-Specific Simulations of Jnk Activity Predict the Survival of Neuroblastoma Patients.” Sci. Signal. 8 (408). American Association for the Advancement of Science: ra130–ra130.

Flake, Gary William. 1998. The Computational Beauty of Nature: Computer Explorations of Fractals, Chaos, Complex Systems, and Adaptation. MIT press.

Flobak, Åsmund, Anaïs Baudot, Elisabeth Remy, Liv Thommesen, Denis Thieffry, Martin Kuiper, and Astrid Lægreid. 2015. “Discovery of Drug Synergies in Gastric Cancer Cells Predicted by Logical Modeling.” PLoS Computational Biology 11 (8). Public Library of Science.

Fowler, Andrew Cadle, Anna C Fowler, and AC Fowler. 1997. Mathematical Models in the Applied Sciences. Vol. 17. Cambridge University Press.

Frigg, Roman, and Stephan Hartmann. 2020. “Models in Science.” In The Stanford Encyclopedia of Philosophy, edited by Edward N. Zalta, Spring 2020. https://plato.stanford.edu/archives/spr2020/entries/models-science/; Metaphysics Research Lab, Stanford University.

Fröhlich, Fabian, Thomas Kessler, Daniel Weindl, Alexey Shadrin, Leonard Schmiester, Hendrik Hache, Artur Muradyan, et al. 2018. “Efficient Parameter Estimation Enables the Prediction of Drug Response Using a Mechanistic Pan-Cancer Pathway Model.” Cell Systems 7 (6). Elsevier: 567–79.

Gao, Hui, Joshua M Korn, Stéphane Ferretti, John E Monahan, Youzhen Wang, Mallika Singh, Chao Zhang, et al. 2015. “High-Throughput Screening Using Patient-Derived Tumor Xenografts to Predict Clinical Trial Drug Response.” Nature Medicine 21 (11). Nature Publishing Group: 1318.

Hahn, William C, Christopher M Counter, Ante S Lundberg, Roderick L Beijersbergen, Mary W Brooks, and Robert A Weinberg. 1999. “Creation of Human Tumour Cells with Defined Genetic Elements.” Nature 400 (6743). Nature Publishing Group: 464–68.

Hajdu, Steven I. 2011a. “A Note from History: Landmarks in History of Cancer, Part 1.” Cancer 117 (5). Wiley Online Library: 1097–1102.

———. 2011b. “A Note from History: Landmarks in History of Cancer, Part 2.” Cancer 117 (12). Wiley Online Library: 2811–20.

———. 2012a. “A Note from History: Landmarks in History of Cancer, Part 3.” Cancer 118 (4). Wiley Online Library: 1155–68.

———. 2012b. “A Note from History: Landmarks in History of Cancer, Part 4.” Cancer 118 (20). Wiley Online Library: 4914–28.

Hajdu, Steven I, and Farbod Darvishian. 2013. “A Note from History: Landmarks in History of Cancer, Part 5.” Cancer 119 (8). Wiley Online Library: 1450–66.

Hajdu, Steven I, and Manjunath Vadmal. 2013. “A Note from History: Landmarks in History of Cancer, Part 6.” Cancer 119 (23). Wiley Online Library: 4058–82.

Hanahan, Douglas, and Robert A Weinberg. 2000. “The Hallmarks of Cancer.” Cell 100 (1). Elsevier: 57–70.

———. 2011. “Hallmarks of Cancer: The Next Generation.” Cell 144 (5). Elsevier: 646–74.

Hasin, Yehudit, Marcus Seldin, and Aldons Lusis. 2017. “Multi-Omics Approaches to Disease.” Genome Biology 18 (1). BioMed Central: 83.

Hastie, Trevor, Robert Tibshirani, and Jerome Friedman. 2009. The Elements of Statistical Learning: Data Mining, Inference, and Prediction. Springer Science & Business Media.

Hector, Suzanne, Markus Rehm, Jasmin Schmid, Joan Kehoe, Niamh McCawley, Patrick Dicker, Frank Murray, et al. 2012. “Clinical Application of a Systems Model of Apoptosis Execution for the Prediction of Colorectal Cancer Therapy Responses and Personalisation of Therapy.” Gut 61 (5). BMJ Publishing Group: 725–33.

Heijblom, Michelle, Linda M Meijer, Ton G van Leeuwen, Wiendelt Steenbergen, and Srirang Manohar. 2014. “Monte Carlo Simulations Shed Light on Bathsheba’s Suspect Breast.” Journal of Biophotonics 7 (5). Wiley Online Library: 323–31.

Helikar, Tomáš, John Konvalina, Jack Heidel, and Jim A Rogers. 2008. “Emergent Decision-Making in Biological Signal Transduction Networks.” Proceedings of the National Academy of Sciences 105 (6). National Acad Sciences: 1913–8.

Henry, N Lynn, and Daniel F Hayes. 2012. “Cancer Biomarkers.” Molecular Oncology 6 (2). Wiley Online Library: 140–46.

Hernán, MA, and JM Robins. 2020. “Causal Inference: What If.” Boca Raton: Chapman & Hill/CRC.

Hewitt, C Gordon. 1917. “Conservation of Wild Life in Canada.” Nature Publishing Group.

Hidalgo, Manuel, Frederic Amant, Andrew V Biankin, Eva Budinská, Annette T Byrne, Carlos Caldas, Robert B Clarke, et al. 2014. “Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research.” Cancer Discovery 4 (9). AACR: 998–1013.

Hornberg, Jorrit J, Frank J Bruggeman, Hans V Westerhoff, and Jan Lankelma. 2006. “Cancer: A Systems Biology Disease.” Biosystems 83 (2-3). Elsevier: 81–90.

Iorio, Francesco, Theo A Knijnenburg, Daniel J Vis, Graham R Bignell, Michael P Menden, Michael Schubert, Nanne Aben, et al. 2016. “A Landscape of Pharmacogenomic Interactions in Cancer.” Cell 166 (3). Elsevier: 740–54.

Ishwaran, Hemant. 2007. “Variable Importance in Binary Regression Trees and Forests.” Electronic Journal of Statistics 1. The Institute of Mathematical Statistics; the Bernoulli Society: 519–37.

Jastrzebski, Katarzyna, Bram Thijssen, Roelof JC Kluin, Klaas de Lint, Ian J Majewski, Roderick L Beijersbergen, and Lodewyk FA Wessels. 2018. “Integrative Modeling Identifies Key Determinants of Inhibitor Sensitivity in Breast Cancer Cell Lines.” Cancer Research 78 (15). AACR: 4396–4410.

Jemal, Ahmedin, Elizabeth M Ward, Christopher J Johnson, Kathleen A Cronin, Jiemin Ma, A Blythe Ryerson, Angela Mariotto, et al. 2017. “Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival.” JNCI: Journal of the National Cancer Institute 109 (9). Oxford University Press: djx030.

Jones, Siân, Xiaosong Zhang, D Williams Parsons, Jimmy Cheng-Ho Lin, Rebecca J Leary, Philipp Angenendt, Parminder Mankoo, et al. 2008. “Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses.” Science 321 (5897). American Association for the Advancement of Science: 1801–6.

Kanehisa, Minoru, Susumu Goto, Yoko Sato, Miho Furumichi, and Mao Tanabe. 2012. “KEGG for Integration and Interpretation of Large-Scale Molecular Data Sets.” Nucleic Acids Research 40 (D1). Oxford University Press: D109–D114.

Kauffman, Stuart. 1969. “Homeostasis and Differentiation in Random Genetic Control Networks.” Nature 224 (5215). Springer: 177–78.

Khan, Faiz M, Stephan Marquardt, Shailendra K Gupta, Susanne Knoll, Ulf Schmitz, Alf Spitschak, David Engelmann, Julio Vera, Olaf Wolkenhauer, and Brigitte M Pützer. 2017. “Unraveling a Tumor Type-Specific Regulatory Core Underlying E2f1-Mediated Epithelial-Mesenchymal Transition to Predict Receptor Protein Signatures.” Nature Communications 8 (1). Nature Publishing Group: 1–15.

Kitano, Hiroaki. 2002. “Computational Systems Biology.” Nature 420 (6912). Nature Publishing Group: 206–10.

Knijnenburg, Theo A, Gunnar W Klau, Francesco Iorio, Mathew J Garnett, Ultan McDermott, Ilya Shmulevich, and Lodewyk FA Wessels. 2016. “Logic Models to Predict Continuous Outputs Based on Binary Inputs with an Application to Personalized Cancer Therapy.” Scientific Reports 6 (1). Nature Publishing Group: 1–14.

Knudson, Alfred G. 1971. “Mutation and Cancer: Statistical Study of Retinoblastoma.” Proceedings of the National Academy of Sciences 68 (4). National Acad Sciences: 820–23.

Knuuttila, Tarja, and Andrea Loettgers. 2017. “Modelling as Indirect Representation? The Lotka–Volterra Model Revisited.” The British Journal for the Philosophy of Science 68 (4). Oxford University Press: 1007–36.

Kreeger, Pamela K, and Douglas A Lauffenburger. 2010. “Cancer Systems Biology: A Network Modeling Perspective.” Carcinogenesis 31 (1). Oxford University Press: 2–8.

Kuperstein, I, E Bonnet, HA Nguyen, D Cohen, E Viara, L Grieco, S Fourquet, et al. 2015. “Atlas of Cancer Signalling Network: A Systems Biology Resource for Integrative Analysis of Cancer Data with Google Maps.” Oncogenesis 4 (7). Nature Publishing Group: e160–e160.

Lander, Eric S. 2011. “Initial Impact of the Sequencing of the Human Genome.” Nature 470 (7333). Nature Publishing Group: 187–97.

Lander, Eric S, Lauren M Linton, Bruce Birren, Chad Nusbaum, Michael C Zody, Jennifer Baldwin, Keri Devon, et al. 2001. “Initial Sequencing and Analysis of the Human Genome.” Macmillan Publishers Ltd.

Le Novere, Nicolas. 2015. “Quantitative and Logic Modelling of Molecular and Gene Networks.” Nature Reviews Genetics 16 (3). Nature Publishing Group: 146–58.

Letort, Gaelle, Arnau Montagud, Gautier Stoll, Randy Heiland, Emmanuel Barillot, Paul Macklin, Andrei Zinovyev, and Laurence Calzone. 2019. “PhysiBoSS: A Multi-Scale Agent-Based Modelling Framework Integrating Physical Dimension and Cell Signalling.” Bioinformatics 35 (7). Oxford University Press: 1188–96.

Liu, Jianfang, Tara Lichtenberg, Katherine A Hoadley, Laila M Poisson, Alexander J Lazar, Andrew D Cherniack, Albert J Kovatich, et al. 2018. “An Integrated Tcga Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.” Cell 173 (2). Elsevier: 400–416.

Lotka, AJ. 1925. “Principles of Physical Biology.” Baltimore: Waverly.

Manica, Matteo, Ali Oskooei, Jannis Born, Vigneshwari Subramanian, Julio Sáez-Rodríguez, and María Rodríguez Martínez. 2019. “Toward Explainable Anticancer Compound Sensitivity Prediction via Multimodal Attention-Based Convolutional Encoders.” Molecular Pharmaceutics. ACS Publications.

Markevich, Nick I, Jan B Hoek, and Boris N Kholodenko. 2004. “Signaling Switches and Bistability Arising from Multisite Phosphorylation in Protein Kinase Cascades.” The Journal of Cell Biology 164 (3). Rockefeller University Press: 353–59.

Meyerson, Matthew, Stacey Gabriel, and Gad Getz. 2010. “Advances in Understanding Cancer Genomes Through Second-Generation Sequencing.” Nature Reviews Genetics 11 (10). Nature Publishing Group: 685–96.

Murphy, Á C, Birgit Weyhenmeyer, Jasmin Schmid, Seán M Kilbride, Markus Rehm, Heinrich J Huber, C Senft, et al. 2013. “Activation of Executioner Caspases Is a Predictor of Progression-Free Survival in Glioblastoma Patients: A Systems Medicine Approach.” Cell Death & Disease 4 (5). Nature Publishing Group: e629–e629.

Navin, Nicholas E. 2015. “The First Five Years of Single-Cell Cancer Genomics and Beyond.” Genome Research 25 (10). Cold Spring Harbor Lab: 1499–1507.

Network, Cancer Genome Atlas Research, and others. 2008. “Comprehensive Genomic Characterization Defines Human Glioblastoma Genes and Core Pathways.” Nature 455 (7216). Nature Publishing Group: 1061.

Network, Cancer Genome Atlas, and others. 2012. “Comprehensive Molecular Portraits of Human Breast Tumours.” Nature 490 (7418). Nature Publishing Group: 61.

Nicolò, Chiara, Cynthia Périer, Melanie Prague, Carine Bellera, Gaëtan MacGrogan, Olivier Saut, and Sébastien Benzekry. 2020. “Machine Learning and Mechanistic Modeling for Prediction of Metastatic Relapse in Early-Stage Breast Cancer.” JCO Clinical Cancer Informatics 4. American Society of Clinical Oncology: 259–74.

Nowell, Peter C. 1976. “The Clonal Evolution of Tumor Cell Populations.” Science 194 (4260). American Association for the Advancement of Science: 23–28.

Oldenhuis, CNAM, SF Oosting, JA Gietema, and EGE De Vries. 2008. “Prognostic Versus Predictive Value of Biomarkers in Oncology.” European Journal of Cancer 44 (7). Elsevier: 946–53.

Pawson, T, and N Warner. 2007. “Oncogenic Re-Wiring of Cellular Signaling Pathways.” Oncogene 26 (9). Nature Publishing Group: 1268–75.

Perfetto, Livia, Leonardo Briganti, Alberto Calderone, Andrea Cerquone Perpetuini, Marta Iannuccelli, Francesca Langone, Luana Licata, et al. 2016. “SIGNOR: A Database of Causal Relationships Between Biological Entities.” Nucleic Acids Research 44 (D1). Oxford University Press: D548–D554.

Perou, Charles M, Stefanie S Jeffrey, Matt Van De Rijn, Christian A Rees, Michael B Eisen, Douglas T Ross, Alexander Pergamenschikov, et al. 1999. “Distinctive Gene Expression Patterns in Human Mammary Epithelial Cells and Breast Cancers.” Proceedings of the National Academy of Sciences 96 (16). National Acad Sciences: 9212–7.

Perou, Charles M, Therese Sørlie, Michael B Eisen, Matt Van De Rijn, Stefanie S Jeffrey, Christian A Rees, Jonathan R Pollack, et al. 2000. “Molecular Portraits of Human Breast Tumours.” Nature 406 (6797). Nature Publishing Group: 747–52.

Polynikis, Athanasios, SJ Hogan, and Mario di Bernardo. 2009. “Comparing Different Ode Modelling Approaches for Gene Regulatory Networks.” Journal of Theoretical Biology 261 (4). Elsevier: 511–30.

Potochnik, Angela. 2017. Idealization and the Aims of Science. University of Chicago Press.

Powathil, Gibin G, Maciej Swat, and Mark AJ Chaplain. 2015. “Systems Oncology: Towards Patient-Specific Treatment Regimes Informed by Multiscale Mathematical Modelling.” In Seminars in Cancer Biology, 30:13–20. Elsevier.

Reddy, E Premkumar, Roberta K Reynolds, Eugenio Santos, and Mariano Barbacid. 1982. “A Point Mutation Is Responsible for the Acquisition of Transforming Properties by the T24 Human Bladder Carcinoma Oncogene.” Nature 300 (5888). Nature Publishing Group: 149–52.

Remy, Elisabeth, Sandra Rebouissou, Claudine Chaouiya, Andrei Zinovyev, François Radvanyi, and Laurence Calzone. 2015. “A Modeling Approach to Explain Mutually Exclusive and Co-Occurring Genetic Alterations in Bladder Tumorigenesis.” Cancer Research 75 (19). AACR: 4042–52.

Reuter, Jason A, Damek V Spacek, and Michael P Snyder. 2015. “High-Throughput Sequencing Technologies.” Molecular Cell 58 (4). Elsevier: 586–97.

Rosenblueth, Arturo, and Norbert Wiener. 1945. “The Role of Models in Science.” Philosophy of Science 12 (4). Williams; Wilkins Co.: 316–21.

Saez-Rodriguez, Julio, Leonidas G Alexopoulos, MingSheng Zhang, Melody K Morris, Douglas A Lauffenburger, and Peter K Sorger. 2011. “Comparing Signaling Networks Between Normal and Transformed Hepatocytes Using Discrete Logical Models.” Cancer Research 71 (16). AACR: 5400–5411.

Salvucci, Manuela, Arman Rahman, Alexa J Resler, Girish M Udupi, Deborah A McNamara, Elaine W Kay, Pierre Laurent-Puig, et al. 2019. “A Machine Learning Platform to Optimize the Translation of Personalized Network Models to the Clinic.” JCO Clinical Cancer Informatics 3. American Society of Clinical Oncology: 1–17.

Salvucci, Manuela, Maximilian L Würstle, Clare Morgan, Sarah Curry, Mattia Cremona, Andreas U Lindner, Orna Bacon, et al. 2017. “A Stepwise Integrated Approach to Personalized Risk Predictions in Stage Iii Colorectal Cancer.” Clinical Cancer Research 23 (5). AACR: 1200–1212.

Samuels, Yardena, Zhenghe Wang, Alberto Bardelli, Natalie Silliman, Janine Ptak, Steve Szabo, Hai Yan, et al. 2004. “High Frequency of Mutations of the Pik3ca Gene in Human Cancers.” Science 304 (5670). American Association for the Advancement of Science: 554–54.

Sanchez-Vega, Francisco, Marco Mina, Joshua Armenia, Walid K Chatila, Augustin Luna, Konnor C La, Sofia Dimitriadoy, et al. 2018. “Oncogenic Signaling Pathways in the Cancer Genome Atlas.” Cell 173 (2). Elsevier: 321–37.

Sawyers, Charles L. 2008. “The Cancer Biomarker Problem.” Nature 452 (7187). Nature Publishing Group: 548–52.

Stadler, Zsofia K, Kasmintan A Schrader, Joseph Vijai, Mark E Robson, and Kenneth Offit. 2014. “Cancer Genomics and Inherited Risk.” Journal of Clinical Oncology 32 (7). American Society of Clinical Oncology: 687.

Stratton, Michael R, Peter J Campbell, and P Andrew Futreal. 2009. “The Cancer Genome.” Nature 458 (7239). Nature Publishing Group: 719–24.

Swanson, Kristin R, Carly Bridge, JD Murray, and Ellsworth C Alvord Jr. 2003. “Virtual and Real Brain Tumors: Using Mathematical Modeling to Quantify Glioma Growth and Invasion.” Journal of the Neurological Sciences 216 (1). Elsevier: 1–10.

Thomas, René. 1973. “Boolean Formalization of Genetic Control Circuits.” Journal of Theoretical Biology 42 (3). Elsevier: 563–85.

Tomasetti, Cristian, and Bert Vogelstein. 2015. “Variation in Cancer Risk Among Tissues Can Be Explained by the Number of Stem Cell Divisions.” Science 347 (6217). American Association for the Advancement of Science: 78–81.

Tomasetti, Cristian, Luigi Marchionni, Martin A Nowak, Giovanni Parmigiani, and Bert Vogelstein. 2015. “Only Three Driver Gene Mutations Are Required for the Development of Lung and Colorectal Cancers.” Proceedings of the National Academy of Sciences 112 (1). National Acad Sciences: 118–23.

Trefois, Christophe, Paul MA Antony, Jorge Goncalves, Alexander Skupin, and Rudi Balling. 2015. “Critical Transitions in Chronic Disease: Transferring Concepts from Ecology to Systems Medicine.” Current Opinion in Biotechnology 34. Elsevier: 48–55.

Türei, Dénes, Tamás Korcsmáros, and Julio Saez-Rodriguez. 2016. “OmniPath: Guidelines and Gateway for Literature-Curated Signaling Pathway Resources.” Nature Methods 13 (12). Nature Publishing Group: 966.

Tyson, John J, William T Baumann, Chun Chen, Anael Verdugo, Iman Tavassoly, Yue Wang, Louis M Weiner, and Robert Clarke. 2011. “Dynamic Modelling of Oestrogen Signalling and Cell Fate in Breast Cancer Cells.” Nature Reviews Cancer 11 (7). Nature Publishing Group: 523–32.

Tyson, John J, Katherine C Chen, and Bela Novak. 2003. “Sniffers, Buzzers, Toggles and Blinkers: Dynamics of Regulatory and Signaling Pathways in the Cell.” Current Opinion in Cell Biology 15 (2). Elsevier: 221–31.

Van’t Veer, Laura J, Hongyue Dai, Marc J Van De Vijver, Yudong D He, Augustinus AM Hart, Mao Mao, Hans L Peterse, et al. 2002. “Gene Expression Profiling Predicts Clinical Outcome of Breast Cancer.” Nature 415 (6871). Nature Publishing Group: 530–36.

Venet, David, Jacques E Dumont, Vincent Detours, and others. 2011. “Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome.” PLoS Comput Biol 7 (10): e1002240.

Venter, J Craig, Mark D Adams, Eugene W Myers, Peter W Li, Richard J Mural, Granger G Sutton, Hamilton O Smith, et al. 2001. “The Sequence of the Human Genome.” Science 291 (5507). American Association for the Advancement of Science: 1304–51.

Villaverde, Alejandro F, and Julio R Banga. 2014. “Reverse Engineering and Identification in Systems Biology: Strategies, Perspectives and Challenges.” Journal of the Royal Society Interface 11 (91). The Royal Society: 20130505.

Volterra, Vito. 1926. “Fluctuations in the Abundance of a Species Considered Mathematically.” Nature Publishing Group.

Vucic, Emily A, Kelsie L Thu, Keith Robison, Leszek A Rybaczyk, Raj Chari, Carlos E Alvarez, and Wan L Lam. 2012. “Translating Cancer ‘Omics’ to Improved Outcomes.” Genome Research 22 (2). Cold Spring Harbor Lab: 188–95.

Wan, Frederick YM. 2018. Mathematical Models and Their Analysis. Vol. 79. SIAM.

Watson, James D, and Francis HC Crick. 1953. “Molecular Structure of Nucleic Acids.” Nature 171 (4356): 737–38.

Weinberg, Robert A. 2013. The Biology of Cancer. Garland science.

Yang, Wanjuan, Jorge Soares, Patricia Greninger, Elena J Edelman, Howard Lightfoot, Simon Forbes, Nidhi Bindal, et al. 2012. “Genomics of Drug Sensitivity in Cancer (Gdsc): A Resource for Therapeutic Biomarker Discovery in Cancer Cells.” Nucleic Acids Research 41 (D1). Oxford University Press: D955–D961.

Zañudo, Jorge Gómez Tejeda, Maurizio Scaltriti, and Réka Albert. 2017. “A Network Modeling Approach to Elucidate Drug Resistance Mechanisms and Predict Combinatorial Drug Treatments in Breast Cancer.” Cancer Convergence 1 (1). Springer: 5.